Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
adult female patient received pediatric dose of Engerix B; adult female patient received pediatric dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 39-year-old female patient who received HBV (Engerix B 10 mcg) for prophylaxis. On 17-JAN-2025, the patient received the 3rd dose of Engerix B 10 mcg. On 17-JAN-2025, an unknown time after receiving Engerix B 10 mcg, the patient experienced adult use of a child product (Verbatim: adult female patient received pediatric dose of Engerix B) and underdose (Verbatim: adult female patient received pediatric dose). The outcome of the adult use of a child product and underdose were not applicable. Additional Information: GSK Receipt date: 22-JAN-2025 The registered nurse reported that an adult female patient received pediatric dose of Engerix B 10 mcg as a third dose which led to underdose and adult use of a child product.